Welcome to our dedicated page for OHAC news (Ticker: OHAC), a resource for investors and traders seeking the latest updates and insights on OHAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OHAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OHAC's position in the market.
Oceanhawk Acquisition (Nasdaq: OHAC) priced an upsized $160 million IPO, offering 16,000,000 units at $10.00 each. Units, trading as OHACU from May 21, 2026, include one Class A share and one right to receive one-fourth of a share after a business combination.
The underwriter has a 45-day option for 2,400,000 additional units. Shares and rights are expected to trade separately as OHAC and OHACR. The SPAC targets high-potential global businesses and expects the offering to close May 22, 2026, following SEC effectiveness on May 20, 2026.